Tamarly Intelligence
Company · CRL (New York Stock Exchange)

Charles River Laboratories International, Inc.

Services-Commercial Physical & Biological Research

Key figures
Revenue, 2025
$4.02B
Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Institutional holders
569 at 30 Jun 2026 (561 the quarter before)
SEC number
1100682
LEI
549300BSQ0R4UZ5KX287

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 27 Oct 2026

About

Charles River Laboratories International, Inc. is a major US biomedical company, headquartered in Wilmington, founded in 1947.

Source: Wikidata

Latest filings
24 Sept 2026
8-K 8-K
5 Aug 2026
8-K 8-K
5 Aug 2026
10-Q 10-Q
11 May 2026
8-K FORM 8-K
7 May 2026
10-Q 10-Q

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Charles River Laboratories International, Inc.: Revenue $4.02B (2025), filings, holders and country risk | Tamarly